Back

Dual endothelin antagonists in hypertension

30 August 2025 (11:00 - 11:15)
Organised by: Logo
Congress Presentation Part of: New drugs in the management of hypertension: global perspectives Hypertension ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Jiguang Wang

Rui Jin Hospital- Shanghai Jiaotong University School of Medicine, Shanghai (China)

3 More presentations in this session

Presentation thumbnail
RNA-targeting therapy in hypertension
Professor C. Granger (Durham, US)
Slides Video
Presentation thumbnail
Aldosterone-targeted therapies in hypertension
Doctor E. Jones (Cape Town, ZA)
Slides Video
Presentation thumbnail
Old vs. new: how will the new therapies be used around the world?
Professor B. Williams (London, GB)
Slides Video

Access the full session

Session thumbnail
New drugs in the management of hypertension: global perspectives
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Dual endothelin receptor antagonist
2 September 2024
thumbnail
Congress Session
Implementation of the 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension: insights from Hong Kong
31 August 2025
thumbnail
Congress Presentation
Safety, tolerability and blood pressure lowering of the innovative guanylyl cyclase a-receptor activator MANP in an ethnically diverse resistant hypertension population: a phase 1B clinical trial
30 August 2024
thumbnail
Congress Presentation
Incretin-based therapy for hypertension
31 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources